BSE:501477

Stock Analysis Report

Muller & Phipps (India)

Executive Summary

Muller & Phipps (India) Limited distributes cosmetic and toiletry, and medicated preparation products in India.


Snowflake Analysis

Solid track record and slightly overvalued.

Share Price & News

How has Muller & Phipps (India)'s share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 501477 has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

0%

501477

-1.1%

IN Retail Distributors

-3.5%

IN Market


1 Year Return

-40.7%

501477

-26.5%

IN Retail Distributors

5.2%

IN Market

Return vs Industry: 501477 underperformed the Indian Retail Distributors industry which returned -26.5% over the past year.

Return vs Market: 501477 underperformed the Indian Market which returned 6.4% over the past year.


Shareholder returns

501477IndustryMarket
7 Day0%-1.1%-3.5%
30 Day1.2%-0.7%-3.9%
90 Dayn/a-4.3%-2.1%
1 Year-40.7%-40.7%-26.2%-26.5%7.2%5.2%
3 Year-73.1%-73.1%-13.4%-14.6%18.9%12.4%
5 Year-72.0%-72.0%-67.9%-68.2%29.4%17.7%

Price Volatility Vs. Market

How volatile is Muller & Phipps (India)'s share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Muller & Phipps (India) undervalued compared to its fair value and its price relative to the market?

3.7x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 501477 (₹25.2) is trading above our estimate of fair value (₹8.83)

Significantly Below Fair Value: 501477 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 501477 is good value based on its PE Ratio (3.7x) compared to the Retail Distributors industry average (65.2x).

PE vs Market: 501477 is good value based on its PE Ratio (3.7x) compared to the Indian market (13x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 501477's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 501477 has negative assets, so we can't compare its PB Ratio to the IN Retail Distributors industry average.


Next Steps

Future Growth

How is Muller & Phipps (India) forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

8.3%

Forecasted Retail industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Muller & Phipps (India) has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Muller & Phipps (India) performed over the past 5 years?

15.1%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 501477 has high quality earnings.

Growing Profit Margin: 501477's current net profit margins (11.2%) are higher than last year (3.8%).


Past Earnings Growth Analysis

Earnings Trend: 501477's earnings have grown by 15.1% per year over the past 5 years.

Accelerating Growth: 501477's earnings growth over the past year (212.7%) exceeds its 5-year average (15.1% per year).

Earnings vs Industry: 501477 earnings growth over the past year (212.7%) exceeded the Retail Distributors industry -10.3%.


Return on Equity

High ROE: 501477's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Next Steps

Financial Health

How is Muller & Phipps (India)'s financial position?


Financial Position Analysis

Short Term Liabilities: 501477 has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: 501477 has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: 501477 has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: 501477's has negative shareholder equity, so we do not need to check if its debt has reduced over time.

Debt Coverage: 501477's debt is not well covered by operating cash flow (3.9%).

Interest Coverage: 501477's interest payments on its debt are not well covered by EBIT (1.2x coverage).


Balance Sheet

Inventory Level: 501477 has a low level of unsold assets or inventory.

Debt Coverage by Assets: 501477 has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.


Next Steps

Dividend

What is Muller & Phipps (India)'s current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate 501477's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate 501477's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 501477's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 501477's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 501477's dividend in 3 years as they are not forecast to pay a notable one for the Indian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

0.9yrs

Average board tenure


CEO

P. Mohan 0

₹971,000

Compensation

Mr. P. V. Mohan serves as the President, Chief Executive Officer, President of Operation and Compliance Officer at Muller & Phipps (India) Limited and serves as its Director since May 10, 2019. 


CEO Compensation Analysis

Compensation vs Market: P.'s total compensation ($USD13.52K) is below average for companies of similar size in the Indian market ($USD49.94K).

Compensation vs Earnings: P.'s compensation has been consistent with company performance over the past year.


Board Members

NamePositionTenureCompensationOwnership
P. Mohan
CEO, President0yrs₹971.00kno data
Milan Dalal
Director13.6yrs₹25.00k0.38% 59.2k
Raymond Simkins
Chairman0yrs₹15.00kno data
Kamlini Maniar
Woman Independent Director4.9yrs₹15.00kno data
Venu Krishnan
Independent Director0.9yrsno datano data
A. Sheshadrinathan
Independent Director0.08yrsno datano data

0.9yrs

Average Tenure

65yo

Average Age

Experienced Board: 501477's board of directors are not considered experienced ( 0.9 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Muller & Phipps (India) Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Muller & Phipps (India) Limited
  • Ticker: 501477
  • Exchange: BSE
  • Founded: 1917
  • Industry: Distributors
  • Sector: Retail
  • Market Cap: ₹15.750m
  • Shares outstanding: 625.00k
  • Website: https://www.mulphico.co.in

Location

  • Muller & Phipps (India) Limited
  • 204 Madhava Building
  • Bandra Kurla Complex
  • Mumbai
  • Maharashtra
  • 400051
  • India

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
501477BSE (Mumbai Stock Exchange)YesEquity SharesININRApr 2008

Biography

Muller & Phipps (India) Limited distributes cosmetic and toiletry, and medicated preparation products in India. It offers medicated dental cream and gum astringent products under the Cavisan brand name and medicated dental gel under the Cavifast brand name; ayurvedic skin ointment under the Nixoderm brand name; and Alfa Plus branded home care products. It provides its products through a network of chemists, general stores, provisional/kirana stores, and supermarkets. The company was incorporated in 1917 and is headquartered in Mumbai, India. The Muller & Phipps (India) Limited is a subsidiary of Development Holding Asia Ltd. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/02/26 12:50
End of Day Share Price2020/02/11 00:00
Earnings2019/12/31
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.